Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.
de Melo GD, Lazarini F, Larrous F, Feige L, Kornobis E, Levallois S, Marchio A, Kergoat L, Hardy D, Cokelaer T, Pineau P, Lecuit M, Lledo PM, Changeux JP, Bourhy H.
de Melo GD, et al. Among authors: kornobis e.
EMBO Mol Med. 2021 Aug 9;13(8):e14122. doi: 10.15252/emmm.202114122. Epub 2021 Jul 12.
EMBO Mol Med. 2021.
PMID: 34170074
Free PMC article.